Teva Misses on Earnings By a Penny, Maintains View
Teva Pharmaceutical Industries Ltd. ( TEVA ) reported first quarter 2014 earnings of $1.22 per American Depositary Share (ADS), a penny short of the Zacks Consensus Estimate but 9% above the year-ago earnings. First quarter revenues grew 2% to $5.001 billion, slightly below the Zacks Consensus Estimate of $5.056 billion. […]